Despite the improvements in surgical and medical therapy for hepatocellular carcinoma
(HCC), recurrence still represents a major issue. Up to 70% of patients can experience HCC …

Introduction Abnormal alternative splicing (AS) contributes to aggressive intrahepatic
invasion and metastatic spread, leading to the high lethality of hepatocellular carcinoma …

Background The primary treatment for eligible patients with hepatocellular carcinoma (HCC)
is curative liver resection, offering a 5-year overall survival (OS) of 60%-80%. Despite this …

The effect of cathelicidin hCAP18/LL-37 in hepatocellular carcinoma (HCC) metastasis
remains unclear. Here, we confirmed that LL-37 expression enhanced endothelial …

The properitoneal fat pad is a distinctive anatomical structure located in the midline of
anterior abdominal wall between the transversalis fascia and parietal peritoneum. It has …

Hepatocellular carcinoma presenting with endobronchial metastases is extremely rare, with
less than 15 cases reported over the last 4 decades. We describe a case of a 62‐year‐old …

Objective Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related
deaths worldwide. This study aims to construct a novel practical nomogram and risk …

Background Extrahepatic metastases and proper staging of HCC are mandatory for proper
assessment of the disease process and its exact extent. Subsequently, clinicians can put …

Hepatocellular Carcinoma (HCC), also known as hepatoma, is the most common type of
primary liver cancer. HCC originates from hepatocytes, which are the main cells of the liver …

BACKGROUND Hepatocellular carcinoma (HCC) is a primary liver cancer with high
prevalence and mortality. There are many cases of advanced HCC at the time of diagnosis …